lentiviral vector vaccines (Immune Design/University of Oxford/The Jenner Institute/California Institute of Technology/Kumamoto University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namelentiviral vector vaccines (Immune Design/University of Oxford/The Jenner Institute/California Institute of Technology/Kumamoto University)
Drug Alias NameZVex.tHIVconsv1ZVex.tHIVconsv2
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Jenner InstituteUniversity Of OxfordKumamoto University +[5] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A